In prostate cancer, caveolin-1 both protects against androgen withdrawal-induced apoptosis in vitro and in vivo (Nasu et al, 1998) and blocks c-myc-induced apoptosis in cancer cells (Timme et al, 2000). This evidence concerns the gene MYC and prostate cancer.